SavedAdd your journal

Journals / Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi / 2020 / Cilt: 53 - Sayı: 1

CONTRAST AGENTS; PHARMACOLOGICAL PROPERTIES, GENERAL ADVERSE REACTIONS AND DRUG INTERACTIONS

KONTRAST AJANLAR; FARMAKOLOJİK ÖZELLİKLERİ, GENEL ADVERS REAKSİYONLARI VE İLAÇ ETKİLEŞİMLERİ

Sonay AYDIN
Özlem ÇELİK AYDIN
Hakkı Zafer GÜNEY
Pages
61–67
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, we aim to summarize the pharmacological properties of contrast agents, their adverse reactions and drug interactions.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Contrast agents are commonly used in general radiological practice.
📊
Key Findings & Data:Contrast agents are classified into two main groups: iodinated contrast agents and gadolinium based ones.
💡
Conclusion & Impact:In this review, we aim to summarize the pharmacological properties of contrast agents, their adverse reactions and drug interactions.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Contrast agents are commonly used in general radiological practice. Contrast agents are classified into two main groups: iodinated contrast agents and gadolinium based ones. In this review, we aim to summarize the pharmacological properties of contrast agents, their adverse reactions and drug interactions.

Özet

Kontrast ajanlar, genel radyoloji pratiğinde sıklıkla kullanılmaktadırlar.Kontrast ajanlar temel olarak iyotlu kontrast ajanlar ve gadolinyumbazlı kontrast ajanlar olarak ayrılırlar. Bu derlemede amaç, genelkontrast ajanlarının temel farmakolojik özelliklerini, uygulamasonrasında görülen advers reaksiyonları ve ilaç etkileşimleriniözetlemektir.

🔖

Cite This Article

AYDIN, S., AYDIN, Ö. Ç., GÜNEY, H. Z. (2022). CONTRAST AGENTS; PHARMACOLOGICAL PROPERTIES, GENERAL ADVERSE REACTIONS AND DRUG INTERACTIONS. Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 53 - Sayı: 1, 61–67. https://ajindex.com/articles/441247

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. )Christiansen C. X-ray contrast media--an overview. Toxicology. 2005;209(2):185-7. 2.)Dickinson MC, Kam PC. Intravascular iodinated contrast media and the anaesthetist. Anaesthesia. 2008;63(6):626-34. 3.)Singh J, Daftary A. Iodinated contrast media and their adverse reactions. Journal of nuclear medicine technology. 2008;36(2):69-74; quiz 6-7. 4.)Pasternak JJ, Williamson EE. Clinical pharmacology, uses, and adverse reactions of iodinated contrast agents: a primer for the non-radiologist. Mayo Clinic proceedings. 2012;87(4):390-402. 5.)Spampinato MV, Abid A, Matheus MG. Current Radiographic Iodinated Contrast Agents. Magnetic resonance imaging clinics of North America. 2017;25(4):697-704. 6.)Boyd B, Zamora CA, Castillo M. Managing Adverse Reactions to Contrast Agents. Magnetic resonance imaging clinics of North America. 2017;25(4):737-42. 7.)Ramalho J, Semelka RC, Ramalho M, Nunes RH, AlObaidy M, Castillo M. Gadolinium-Based Contrast Agent Accumulation and Toxicity: An Update. AJNR American journal of neuroradiology. 2016;37(7):1192-8. 8.)Hao D, Ai T, Goerner F, Hu X, Runge VM, Tweedle M. MRI contrast agents: basic chemistry and safety. Journal of magnetic resonance imaging: JMRI. 2012;36(5):1060-71. 9.)Todd DJ, Kay J. Gadolinium-Induced Fibrosis. Annual review of medicine. 2016;67:273-91. 10.)Ramalho M, Ramalho J. Gadolinium-Based Contrast Agents: Associated Adverse Reactions. Magnetic resonance imaging clinics of North America. 2017;25(4):755-64. 11.)Layne KA, Dargan PI, Archer JRH, Wood DM. Gadolinium deposition and the potential for toxicological sequelae - A literature review of issues surrounding gadolinium-based contrast agents. British journal of clinical pharmacology. 2018;84(11):2522-34. 12.)Beckett KR, Moriarity AK, Langer JM. Safe Use of Contrast Media: What the Radiologist Needs to Know. Radiographics: a review publication of the Radiological Society of North America, Inc. 2015;35(6):1738-50. 13.)Bettmann MA. Frequently asked questions: iodinated contrast agents. Radiographics: a review publication of the Radiological Society of North America, Inc. 2004;24 Suppl 1:S3-10. 14.)Perazella MA. Gadolinium-contrast toxicity in patients with kidney disease: nephrotoxicity and nephrogenic systemic fibrosis. Current drug safety. 2008;3(1):67-75. 15.)Mamoulakis C, Tsarouhas K, Fragkiadoulaki I, Heretis I, Wilks MF, Spandidos DA, et al. Contrast-induced nephropathy: Basic concepts, pathophysiological implications and prevention strategies. Pharmacolog